BA
HITK

BlackRock Advisors’s HI-TECH PHARMACAL INC HITK Stock Holding History

BlackRock Advisors’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,939
Closed -$344K – 3787
2014
Q1 		$344K Buy
7,939
+649
+9% +$28.1K ﹤0.01% 2322
2013
Q4 		$316K Buy
7,290
+510
+8% +$22K ﹤0.01% 2360
2013
Q3 		$293K Sell
6,780
-14,188
-68% -$543K ﹤0.01% 2298
2013
Q2 		$696K Buy
+20,968
New +$698K ﹤0.01% 1583

BlackRock Advisors's HITK Position: Q2 2014 in Review

BlackRock Advisors sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 7,939 shares — an estimated $344K sold.

BlackRock Advisors first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $696K in Q2 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • BlackRock Advisors reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • BlackRock Advisors sold 7,939 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $344K.
  • BlackRock Advisors first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • BlackRock Advisors's HI-TECH PHARMACAL INC position peaked at $696K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.